Does Helicobacter pylori infection increase autoimmune thyroid disease and thyroid autoantibody positivity?

Helicobacter pylori infection is increasingly recognized not only as a gastric pathogen but also as a significant driver of systemic immune responses. Research indicates a robust association between this infection and autoimmune thyroid diseases (AITD), characterized by elevated levels of thyroid autoantibodies and a state of chronic, low-grade systemic inflammation.

Clinical and Effectiveness Evidence

Extensive meta-analyses and observational studies consistently link H. pylori infection with an increased prevalence of Hashimoto's thyroiditis and Graves' disease.

• AITD Risk: Meta-analyses of over 3,000 participants show that individuals with H. pylori are significantly more likely to have AITD, with odds ratios (OR) typically ranging from 2.16 to 3.23.
• Autoantibody Positivity: Infected individuals exhibit higher rates of thyroid peroxidase (TPOAb) and thyroglobulin (TgAb) autoantibodies. Some Mendelian randomization studies suggest a potential causal direction between certain H. pylori antibodies and the risk of hyperthyroidism.
• Systemic Inflammation: The infection is associated with elevated high-sensitivity C-reactive protein (hs-CRP), a key marker of systemic inflammation. Clinical data show that successful eradication of H. pylori significantly reduces circulating CRP levels, confirming its role in maintaining a systemic immune-active state.

Mechanistic Explanations

The primary driver for this association is a phenomenon known as molecular mimicry.

• Antigenic Cross-Reactivity: Virulent strains of H. pylori, particularly those expressing the CagA protein, share structural similarities (epitopes) with thyroid proteins such as TPO and thyroglobulin.
• Immune Cascade: When the body produces antibodies against H. pylori antigens, these antibodies can mistakenly cross-react with thyroid tissue. This process, coupled with the release of pro-inflammatory cytokines like IL-1β, IL-6, and IL-8, triggers a systemic Th1/Th17-dominated immune cascade, lowering the threshold for autoimmune activation.

Bottom line

H. pylori infection is strongly associated with autoimmune thyroid disease and higher thyroid autoantibody positivity. This relationship is driven by molecular mimicry and chronic systemic inflammation, both of which can be mitigated through targeted eradication therapy.